Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Calum A MacRae

Showing results (181-190 of 275) with videos related to

Pageof 28
Sort By:
Genome Biology|January 31, 2015
Prioritizing causal disease genes using unbiased genomic featuresRahul C Deo, Gabriel Musso, Murat Tasan, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 25, 2015
Glucocorticoids enhance muscle endurance and ameliorate Duchenne muscular dystrophy through a defined metabolic programAlexander Morrison-Nozik, Priti Anand, Han Zhu, et al.
ESC Heart Failure|August 15, 2024
Characterization and natural history of patients with LMNA-related dilated cardiomyopathy in the phase 3 REALM-DCM trialPablo Garcia-Pavia, Neal K Lakdawala, Gianfranco Sinagra, et al.
American Heart Journal|September 5, 2021
Population health management of low-density lipoprotein cholesterol via a remote, algorithmic, navigator-executed programJorge Plutzky, Mark D Benson, Kira Chaney, et al.
The American Journal of Cardiology|July 7, 2012
Management strategy in 249 consecutive patients with obstructive hypertrophic cardiomyopathy referred to a dedicated programRichard D Rothman, Aaron L Baggish, Caitlin O'Callaghan, et al.
Science Translational Medicine|June 13, 2014
Identification of a new modulator of the intercalated disc in a zebrafish model of arrhythmogenic cardiomyopathyAngeliki Asimaki, Sudhir Kapoor, Eva Plovie, et al.
Future Cardiology|January 31, 2023
Plain Language Summary of Publication of the safety and efficacy of ARRY-371797 in people with dilated cardiomyopathy and a faulty <i>LMNA</i> geneCalum A MacRae, Matthew Rg Taylor, Luisa Mestroni, et al.
American Heart Journal|April 30, 2017
The Design of the Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) TrialCarolyn Y Ho, John J V McMurray, Allison L Cirino, et al.
Nature Genetics|March 1, 2005
Mutation in the transcriptional coactivator EYA4 causes dilated cardiomyopathy and sensorineural hearing lossJost Schönberger, Libin Wang, Jordan T Shin, et al.
Scientific Reports|June 1, 2026
A pilot study in the swine model of lethal cyanide intoxication indicates efficacy of a platinum-methionine complex countermeasureVallabh Suresh, Tara Hendry-Hofer, Matthew M Behymer, et al.
Pageof 28

Showing results (181-190 of 275) with videos related to

Sort By:
Pageof 28
Genome Biology|January 31, 2015
Prioritizing causal disease genes using unbiased genomic featuresRahul C Deo, Gabriel Musso, Murat Tasan, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 25, 2015
Glucocorticoids enhance muscle endurance and ameliorate Duchenne muscular dystrophy through a defined metabolic programAlexander Morrison-Nozik, Priti Anand, Han Zhu, et al.
ESC Heart Failure|August 15, 2024
Characterization and natural history of patients with LMNA-related dilated cardiomyopathy in the phase 3 REALM-DCM trialPablo Garcia-Pavia, Neal K Lakdawala, Gianfranco Sinagra, et al.
American Heart Journal|September 5, 2021
Population health management of low-density lipoprotein cholesterol via a remote, algorithmic, navigator-executed programJorge Plutzky, Mark D Benson, Kira Chaney, et al.
The American Journal of Cardiology|July 7, 2012
Management strategy in 249 consecutive patients with obstructive hypertrophic cardiomyopathy referred to a dedicated programRichard D Rothman, Aaron L Baggish, Caitlin O'Callaghan, et al.
Science Translational Medicine|June 13, 2014
Identification of a new modulator of the intercalated disc in a zebrafish model of arrhythmogenic cardiomyopathyAngeliki Asimaki, Sudhir Kapoor, Eva Plovie, et al.
Future Cardiology|January 31, 2023
Plain Language Summary of Publication of the safety and efficacy of ARRY-371797 in people with dilated cardiomyopathy and a faulty <i>LMNA</i> geneCalum A MacRae, Matthew Rg Taylor, Luisa Mestroni, et al.
American Heart Journal|April 30, 2017
The Design of the Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) TrialCarolyn Y Ho, John J V McMurray, Allison L Cirino, et al.
Nature Genetics|March 1, 2005
Mutation in the transcriptional coactivator EYA4 causes dilated cardiomyopathy and sensorineural hearing lossJost Schönberger, Libin Wang, Jordan T Shin, et al.
Scientific Reports|June 1, 2026
A pilot study in the swine model of lethal cyanide intoxication indicates efficacy of a platinum-methionine complex countermeasureVallabh Suresh, Tara Hendry-Hofer, Matthew M Behymer, et al.
Pageof 28